These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7449299)

  • 21. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.
    WOOD AJ
    Br J Clin Pharmacol; 1977 Apr; 4(2):240-1. PubMed ID: 861140
    [No Abstract]   [Full Text] [Related]  

  • 23. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H; Leth A; McNair A; Giese J
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gas chromatographic-mass spectrometric differentiation of atenolol, metoprolol, propranolol, and an interfering metabolite product of metoprolol.
    Angier MK; Lewis RJ; Chaturvedi AK; Canfield DV
    J Anal Toxicol; 2005 Sep; 29(6):517-21. PubMed ID: 16168172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
    Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
    Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interindividual variation of beta-adrenoceptor blocking drugs, plasma concentration and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol.
    Dayer P; Leemann T; Marmy A; Rosenthaler J
    Eur J Clin Pharmacol; 1985; 28(2):149-53. PubMed ID: 2859203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.
    Kendall MJ; Jack DB; Laugher SJ; Lobo J; Rolf Smith S
    Br J Clin Pharmacol; 1984 Sep; 18(3):331-5. PubMed ID: 6487472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of four beta-blockers as assessed by 24-hour ECG recording.
    Escoubet B; Leclercq JF; Maison-Blanche P; Poirier JM; Gourmel B; Delhotal-Landes B; Coumel P
    Clin Pharmacol Ther; 1986 Apr; 39(4):361-8. PubMed ID: 3956052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
    Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
    [No Abstract]   [Full Text] [Related]  

  • 32. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
    Taylor EA; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, central nervous system uptake, and lipid solubility of propranolol, acebutolol, and sotalol.
    Arendt RM; Greenblatt DJ; deJong RH; Bonin JD; Abernethy DR
    Cardiology; 1984; 71(6):307-14. PubMed ID: 6151871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers and central nervous system side effects.
    McAinsh J; Cruickshank JM
    Pharmacol Ther; 1990; 46(2):163-97. PubMed ID: 1969642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
    Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
    Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of the bioavailability of propranolol and metoprolol by food.
    Melander A; Danielson K; Scherstén B; Wåhlin E
    Clin Pharmacol Ther; 1977 Jul; 22(1):108-12. PubMed ID: 872491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective assay of beta-receptor antagonists present in microdialysis and plasma samples of rats.
    Johansson M; Sjöberg P; Hesselgren AM; Salmonson T
    Chirality; 1995; 7(4):290-6. PubMed ID: 7640173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of beta-blockade on baroreflex sensitivity and cardiovascular autonomic function tests in patients with coronary artery disease.
    Airaksinen KE; Niemelä MJ; Huikuri HV
    Eur Heart J; 1994 Nov; 15(11):1482-5. PubMed ID: 7835362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.